Psychedelic biotech startup Psylo raises $1.1m to treat mental health issues with the key ingredient in magic mushrooms
Sydney psychedelic biotech Psylo has raised $1.1 million in a round led by Possible Ventures, with angel Daniel Petre also backing it, to develop shorter-acting psilocybin-inspired mental health medicines.